logo

MDXG

MiMedx Group·NASDAQ
--
--(--)
--
--(--)
2.31 / 10
Underperform

MDXG's fundamental profile is concerning, rated 'Underperform' with a 2.3/10 score. The Net profit / Total profit ratio of 75.08% falls in the least favorable quartile (score 0), while Asset-MV is also negative (-0.5007, quartile 1). Conversely, Profit-MV (0.3406) and Cash-MV (-0.1351) show mixed signals, and high Gross profit margin (82.046%) offers some cushion. Historical back-tests reveal low average monthly returns (e.g., -0.30% for Net profit / Total profit) and modest confidence levels, underscoring operational and profitability risks.

Fundamental(2.31)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-0.23
Score1/3
Weight15.09%
1M Return5.20%
Inventory turnover ratio
Value2.15
Score2/3
Weight-5.73%
1M Return-2.63%
Gross profit margin (%)
Value82.05
Score2/3
Weight3.73%
1M Return1.47%
Profit-MV
Value0.34
Score2/3
Weight22.59%
1M Return7.79%
PB-ROE
Value2.18
Score2/3
Weight31.71%
1M Return10.68%
Current assets turnover ratio
Value1.35
Score2/3
Weight2.64%
1M Return1.15%
Fixed assets turnover ratio
Value54.91
Score2/3
Weight0.29%
1M Return0.12%
Asset-MV
Value-0.50
Score0/3
Weight7.72%
1M Return2.94%
Cash-MV
Value-0.14
Score2/3
Weight22.62%
1M Return7.73%
Net profit / Total profit (%)
Value75.08
Score0/3
Weight-0.67%
1M Return-0.30%
Is MDXG fundamentally strong?
  • MDXG scores 2.31/10 on fundamentals and holds a Premium valuation at present. Backed by its 15.46% ROE, 10.38% net margin, 18.68 P/E ratio, 3.19 P/B ratio, and -56.25% earnings growth, these metrics solidify its Underperform investment rating.